Recent genetic studies indicated that a rare loss-of-function variant in the ASGR1, resulted in a significant reduction in blood levels of “non-HDL” cholesterol, and a 34% reduction in cardiovascular diseases  risk [16]. This evidence concerns the gene ASGR1 and cardiovascular disorder.